PD-1 signaling in HIV and chronic viral infection - Potential for therapeutic intervention?

Current Medicinal Chemistry

Volumn 18, Issue 26, 2011, Pages 3971-3980

  Eichbaum, Q ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV; PD 1; Signaling; T cell receptor; Therapeutic intervention; Vaccine

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; PHOSPHOPROTEIN; PROGRAMMED DEATH 1 RECEPTOR; PROGRAMMED DEATH 1 RECEPTOR ANTIBODY; PROTEIN CSK; PROTEIN KINASE LCK; PROTEIN KINASE ZAP 70; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; RECEPTOR ANTIBODY; SMALL INTERFERING RNA; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; CELL LINE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; MOLECULAR MODEL; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION; VIRUS INFECTION; VIRUS LOAD;

CHRONIC DISEASE; HIV INFECTIONS; HIV-1; HUMANS; PROGRAMMED CELL DEATH 1 RECEPTOR;

EID: 80052256542     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711796957239     Document Type: Review

References (97)

1. Agata, Y.; Kawasaki, A.; Nishimura, H.; Ishida, Y.; Tsubata, T.; Yagita, H.; Honjo, T., Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 1996, 8 (5), 765-72. (Pubitemid 26148299)
2. Keir, M. E.; Liang, S. C.; Guleria, I.; Latchman, Y. E.; Qipo, A.; Albacker, L. A.; Koulmanda, M.; Freeman, G. J.; Sayegh, M. H.; Sharpe, A. H., Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med 2006, 203 (4), 883-95.
3. Borkow, G.; Bentwich, Z., Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin Microbiol Rev 2004, 17 (4), 1012-30, table of contents (Pubitemid 39372528)
4. Cai, G.; Karni, A.; Oliveira, E. M.; Weiner, H. L.; Hafler, D. A.; Freeman, G. J., PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells. Cell Immunol 2004, 230 (2), 89-98. (Pubitemid 39626650)
5. Day, C. L.; Kaufmann, D. E.; Kiepiela, P.; Brown, J. A.; Moodley, E. S.; Reddy, S.; Mackey, E. W.; Miller, J. D.; Leslie, A. J.; DePierres, C.; Mncube, Z.; Duraiswamy, J.; Zhu, B.; Eichbaum, Q.; Altfeld, M.; Wherry, E. J.; Coovadia, H. M.; Goulder, P. J.; Klenerman, P.; Ahmed, R.; Freeman, G. J.; Walker, B. D., PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006, 443 (7109), 350-4 (Pubitemid 44435155)
6. Trautmann, L.; Janbazian, L.; Chomont, N.; Said, E. A.; Gimmig, S.; Bessette, B.; Boulassel, M. R.; Delwart, E.; Sepulveda, H.; Balderas, R. S.; Routy, J. P.; Haddad, E. K.; Sekaly, R. P., Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006, 12 (10), 1198-202. (Pubitemid 44527357)
7. Latchman, Y.; Wood, C. R.; Chernova, T.; Chaudhary, D.; Borde, M.; Chernova, I.; Iwai, Y.; Long, A. J.; Brown, J. A.; Nunes, R.; Greenfield, E. A.; Bourque, K.; Boussiotis, V. A.; Carter, L. L.; Carreno, B. M.; Malenkovich, N.; Nishimura, H.; Okazaki, T.; Honjo, T.; Sharpe, A. H.; Freeman, G. J., PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001, 2 (3), 261-8. (Pubitemid 33706004)
8. Freeman, G. J.; Wherry, E. J.; Ahmed, R.; Sharpe, A. H., Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J Exp Med 2006, 203 (10), 2223-7. (Pubitemid 44498355)
9. Iwai, Y.; Terawaki, S.; Ikegawa, M.; Okazaki, T.; Honjo, T., PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 2003, 198 (1), 39-50. (Pubitemid 36870184)
10. Barber, D. L.; Wherry, E. J.; Masopust, D.; Zhu, B.; Allison, J. P.; Sharpe, A. H.; Freeman, G. J.; Ahmed, R., Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439 (7077), 682-7. (Pubitemid 43237609)
11. Petrovas, C.; Casazza, J. P.; Brenchley, J. M.; Price, D. A.; Gostick, E.; Adams, W. C.; Precopio, M. L.; Schacker, T.; Roederer, M.; Douek, D. C.; Koup, R. A., PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med 2006, 203 (10), 2281-92. (Pubitemid 44498363)
12. Wherry, E. J.; Blattman, J. N.; Murali-Krishna, K.; van der Most, R.; Ahmed, R., Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 2003, 77 (8), 4911-27. (Pubitemid 36402840)
13. Champagne, P.; Ogg, G. S.; King, A. S.; Knabenhans, C.; Ellefsen, K.; Nobile, M.; Appay, V.; Rizzardi, G. P.; Fleury, S.; Lipp, M.; Forster, R.; Rowland-Jones, S.; Sekaly, R. P.; McMichael, A. J.; Pantaleo, G., Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001, 410 (6824), 106-11. (Pubitemid 32225845)
14. Chomont, N.; El-Far, M.; Ancuta, P.; Trautmann, L.; Procopio, F. A.; Yassine-Diab, B.; Boucher, G.; Boulassel, M. R.; Ghattas, G.; Brenchley, J. M.; Schacker, T. W.; Hill, B. J.; Douek, D. C.; Routy, J. P.; Haddad, E. K.; Sekaly, R. P., HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009, 15 (8), 893-900.
15. Hryniewicz, A.; Boasso, A.; Edghill-Smith, Y.; Vaccari, M.; Fuchs, D.; Venzon, D.; Nacsa, J.; Betts, M. R.; Tsai, W. P.; Heraud, J. M.; Beer, B.; Blanset, D.; Chougnet, C.; Lowy, I.; Shearer, G. M.; Franchini, G., CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood 2006, 108 (12), 3834-42. (Pubitemid 44864566)
16. Zaunders, J. J.; Ip, S.; Munier, M. L.; Kaufmann, D. E.; Suzuki, K.; Brereton, C.; Sasson, S. C.; Seddiki, N.; Koelsch, K.; Landay, A.; Grey, P.; Finlayson, R.; Kaldor, J.; Rosenberg, E. S.; Walker, B. D.; Fazekas de St Groth, B.; Cooper, D. A.; Kelleher, A. D., Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection. J Virol 2006, 80 (20), 10162-72. (Pubitemid 44522609)
17. Riley, J. L.; June, C. H., The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood 2005, 105 (1), 13-21. (Pubitemid 40053057)
18. Riley, J. L., PD-1 signaling in primary T cells. Immunol Rev 2009, 229 (1), 114-25.
19. Butte, M. J.; Keir, M. E.; Phamduy, T. B.; Sharpe, A. H.; Freeman, G. J., Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 2007, 27 (1), 111-22. (Pubitemid 47089023)
20. Shiratori, T.; Miyatake, S.; Ohno, H.; Nakaseko, C.; Isono, K.; Bonifacino, J. S.; Saito, T., Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity 1997, 6 (5), 583-9. (Pubitemid 27239349)
21. Chemnitz, J. M.; Parry, R. V.; Nichols, K. E.; June, C. H.; Riley, J. L., SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol 2004, 173 (2), 945-54. (Pubitemid 38924267)
22. Chikuma, S.; Bluestone, J. A., CTLA-4 and tolerance: the biochemical point of view. Immunol Res 2003, 28 (3), 241-53. (Pubitemid 38091062)
23. Parry, R. V.; Chemnitz, J. M.; Frauwirth, K. A.; Lanfranco, A. R.; Braunstein, I.; Kobayashi, S. V.; Linsley, P. S.; Thompson, C. B.; Riley, J. L., CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 2005, 25 (21), 9543-53. (Pubitemid 41507854)
24. Ishida, Y.; Agata, Y.; Shibahara, K.; Honjo, T., Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 1992, 11 (11), 3887-95.
25. Neel, B. G.; Gu, H.; Pao, L., The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 2003, 28 (6), 284-93. (Pubitemid 36776291)
26. Marengere, L. E.; Waterhouse, P.; Duncan, G. S.; Mittrucker, H. W.; Feng, G. S.; Mak, T. W., Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 1996, 272 (5265), 1170-3. (Pubitemid 26169471)
27. Tsui, F. W.; Martin, A.; Wang, J.; Tsui, H. W., Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1. Immunol Res 2006, 35 (1-2), 127-36. (Pubitemid 44547508)
28. Fry, A. M.; Lanier, L. L.; Weiss, A., Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J Exp Med 1996, 184 (1), 295-300 (Pubitemid 26247241)
29. Avril, T.; Freeman, S. D.; Attrill, H.; Clarke, R. G.; Crocker, P. R., Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation. J Biol Chem 2005, 280 (20), 19843-51. (Pubitemid 41379511)
30. Ulyanova, T.; Blasioli, J.; Thomas, M. L., Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1. Immunol Res 1997, 16 (1), 101-13. (Pubitemid 27129632)
31. Plas, D. R.; Johnson, R.; Pingel, J. T.; Matthews, R. J.; Dalton, M.; Roy, G.; Chan, A. C.; Thomas, M. L., Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling. Science 1996, 272 (5265), 1173-6 (Pubitemid 26169472)
32. Pani, G.; Kozlowski, M.; Cambier, J. C.; Mills, G. B.; Siminovitch, K. A., Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. J Exp Med 1995, 181 (6), 2077-84
33. Lorenz, U.; Ravichandran, K. S.; Burakoff, S. J.; Neel, B. G., Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness. Proc Natl Acad Sci U S A 1996, 93 (18), 9624-9. (Pubitemid 26296658)
34. Stofega, M. R.; Herrington, J.; Billestrup, N.; Carter-Su, C., Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GHpromoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B. Mol Endocrinol 2000, 14 (9), 1338-50
35. Lehmann, U.; Schmitz, J.; Weissenbach, M.; Sobota, R. M.; Hortner, M.; Friederichs, K.; Behrmann, I.; Tsiaris, W.; Sasaki, A.; Schneider-Mergener, J.; Yoshimura, A.; Neel, B. G.; Heinrich, P. C.; Schaper, F., SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130. J Biol Chem 2003, 278 (1), 661-71 (Pubitemid 36043620)
36. Yusa, S.; Catina, T. L.; Campbell, K. S., SHP-1-and phosphotyrosine- independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells. J Immunol 2002, 168 (10), 5047-57. (Pubitemid 34495968)
37. Staub, E.; Rosenthal, A.; Hinzmann, B., Systematic identification of immunoreceptor tyrosine-based inhibitory motifs in the human proteome. Cell Signal 2004, 16 (4), 435-56. (Pubitemid 38058627)
38. Sharpe, A. H.; Freeman, G. J., The B7-CD28 superfamily. Nat Rev Immunol 2002, 2 (2), 116-26. (Pubitemid 37323235)
39. Ward, S. G.; Westwick, J.; Hall, N. D.; Sansom, D. M., Ligation of CD28 receptor by B7 induces formation of D-3 phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation. Eur J Immunol 1993, 23 (10), 2572-7. (Pubitemid 23295141)
40. Fox, C. J.; Hammerman, P. S.; Thompson, C. B., Fuel feeds function: energy metabolism and the T-cell response. Nat Rev Immunol 2005, 5 (11), 844-52. (Pubitemid 41581666)
41. Carter, L.; Fouser, L. A.; Jussif, J.; Fitz, L.; Deng, B.; Wood, C. R.; Collins, M.; Honjo, T.; Freeman, G. J.; Carreno, B. M., PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 2002, 32 (3), 634-43. (Pubitemid 34257540)
42. Cannons, J. L.; Schwartzberg, P. L., Fine-tuning lymphocyte regulation: what's new with tyrosine kinases and phosphatases? Curr Opin Immunol 2004, 16 (3), 296-303. (Pubitemid 38595368)
43. Dustin, M. L.; Chan, A. C., Signaling takes shape in the immune system. Cell 2000, 103 (2), 283-94.
44. Stefanova, I.; Hemmer, B.; Vergelli, M.; Martin, R.; Biddison, W. E.; Germain, R. N., TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nat Immunol 2003, 4 (3), 248-54. (Pubitemid 36322134)
45. Watts, J. D.; Brabb, T.; Bures, E. J.; Wange, R. L.; Samelson, L. E.; Aebersold, R., Identification and characterization of a substrate specific for the T cell protein tyrosine kinase ZAP-70. FEBS Lett 1996, 398 (2-3), 217-22. (Pubitemid 26414313)
46. Yokosuka, T.; Sakata-Sogawa, K.; Kobayashi, W.; Hiroshima, M.; Hashimoto-Tane, A.; Tokunaga, M.; Dustin, M. L.; Saito, T., Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76. Nat Immunol 2005, 6 (12), 1253-62. (Pubitemid 43045637)
47. Sheppard, K. A.; Fitz, L. J.; Lee, J. M.; Benander, C.; George, J. A.; Wooters, J.; Qiu, Y.; Jussif, J. M.; Carter, L. L.; Wood, C. R.; Chaudhary, D., PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. FEBS Lett 2004, 574 (1-3), 37-41. (Pubitemid 39200891)
48. Cheng, A. M.; Negishi, I.; Anderson, S. J.; Chan, A. C.; Bolen, J.; Loh, D. Y.; Pawson, T., The Syk and ZAP-70 SH2-containing tyrosine kinases are implicated in pre-T cell receptor signaling. Proc Natl Acad Sci U S A 1997, 94 (18), 9797-801. (Pubitemid 27408144)
49. Zikherman, J.; Jenne, C.; Watson, S.; Doan, K.; Raschke, W.; Goodnow, C. C.; Weiss, A., CD45-Csk phosphatase-kinase titration uncouples basal and inducible T cell receptor signaling during thymic development. Immunity 2010, 32 (3), 342-54.
50. Weiss, A.; Chan, A. C.; Iwashima, M.; Straus, D.; Irving, B. A., Regulation of protein tyrosine kinase activation by the T-cell antigen receptor zeta chain. Cold Spring Harb Symp Quant Biol 1992, 57, 107-16. (Pubitemid 23174382)
51. Nada, S.; Okada, M.; MacAuley, A.; Cooper, J. A.; Nakagawa, H., Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nature 1991, 351 (6321), 69-72. (Pubitemid 21896537)
52. McNeill, L.; Cassady, R. L.; Sarkardei, S.; Cooper, J. C.; Morgan, G.; Alexander, D. R., CD45 isoforms in T cell signalling and development. Immunol Lett 2004, 92 (1-2), 125-34. (Pubitemid 38470059)
53. Davidson, D.; Schraven, B.; Veillette, A., PAG-associated FynT regulates calcium signaling and promotes anergy in T lymphocytes. Mol Cell Biol 2007, 27 (5), 1960-73.
54. Verbrugge, A.; Rijkers, E. S.; de Ruiter, T.; Meyaard, L., Leukocyteassociated Ig-like receptor-1 has SH2 domain-containing phosphataseindependent function and recruits C-terminal Src kinase. Eur J Immunol 2006, 36 (1), 190-8. (Pubitemid 43116405)
55. Chiang, G. G.; Sefton, B. M., Specific dephosphorylation of the Lck tyrosine protein kinase at Tyr-394 by the SHP-1 protein-tyrosine phosphatase. J Biol Chem 2001, 276 (25), 23173-8.
56. Hermiston, M. L.; Xu, Z.; Weiss, A., CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 2003, 21, 107-37. (Pubitemid 37174528)
57. Binstadt, B. A.; Billadeau, D. D.; Jevremovic, D.; Williams, B. L.; Fang, N.; Yi, T.; Koretzky, G. A.; Abraham, R. T.; Leibson, P. J., SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors. J Biol Chem 1998, 273 (42), 27518-23. (Pubitemid 28500472)
58. Muthumani, K.; Choo, A. Y.; Shedlock, D. J.; Laddy, D. J.; Sundaram, S. G.; Hirao, L.; Wu, L.; Thieu, K. P.; Chung, C. W.; Lankaraman, K. M.; Tebas, P.; Silvestri, G.; Weiner, D. B., Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism. J Virol 2008, 82 (23), 11536-44.
59. Oestreich, K. J.; Yoon, H.; Ahmed, R.; Boss, J. M., NFATc1 regulates PD-1 expression upon T cell activation. J Immunol 2008, 181 (7), 4832-9.
60. Agnellini, P.; Wolint, P.; Rehr, M.; Cahenzli, J.; Karrer, U.; Oxenius, A., Impaired NFAT nuclear translocation results in split exhaustion of virusspecific CD8+ T cell functions during chronic viral infection. Proc Natl Acad Sci U S A 2007, 104 (11), 4565-70. (Pubitemid 47186265)
61. Zheng, Y.; Zha, Y.; Gajewski, T. F., Molecular regulation of T-cell anergy. EMBO Rep 2008, 9 (1), 50-5.
62. Shamim, M.; Nanjappa, S. G.; Singh, A.; Plisch, E. H.; LeBlanc, S. E.; Walent, J.; Svaren, J.; Seroogy, C.; Suresh, M., Cbl-b regulates antigeninduced TCR down-regulation and IFN-gamma production by effector CD8 T cells without affecting functional avidity. J Immunol 2007, 179 (11), 7233-43
63. Ou, R.; Zhang, M.; Huang, L.; Moskophidis, D., Control of virusspecific CD8+ T-cell exhaustion and immune-mediated pathology by E3 ubiquitin ligase Cbl-b during chronic viral infection. J Virol 2008, 82 (7), 3353-68. (Pubitemid 351429913)
64. Anandasabapathy, N.; Ford, G. S.; Bloom, D.; Holness, C.; Paragas, V.; Seroogy, C.; Skrenta, H.; Hollenhorst, M.; Fathman, C. G.; Soares, L., GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity 2003, 18 (4), 535-47. (Pubitemid 36513635)
65. Bennett, F.; Luxenberg, D.; Ling, V.; Wang, I. M.; Marquette, K.; Lowe, D.; Khan, N.; Veldman, G.; Jacobs, K. A.; Valge-Archer, V. E.; Collins, M.; Carreno, B. M., Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J Immunol 2003, 170 (2), 711-8. (Pubitemid 36070520)
66. Kinter, A. L.; Godbout, E. J.; McNally, J. P.; Sereti, I.; Roby, G. A.; O'Shea, M. A.; Fauci, A. S., The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol 2008, 181 (10), 6738-46.
67. King, C.; Ilic, A.; Koelsch, K.; Sarvetnick, N., Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004, 117 (2), 265-77 (Pubitemid 38496245)
68. Baccala, R.; Theofilopoulos, A. N., The new paradigm of Tcell homeostatic proliferation-induced autoimmunity. Trends Immunol 2005, 26 (1), 5-8 (Pubitemid 40051984)
69. Krupica, T., Jr.; Fry, T. J.; Mackall, C. L., Autoimmunity during lymphopenia: a two-hit model. Clin Immunol 2006, 120 (2), 121-8. (Pubitemid 44088681)
70. Brooks, D. G.; Trifilo, M. J.; Edelmann, K. H.; Teyton, L.; McGavern, D. B.; Oldstone, M. B., Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006, 12 (11), 1301-9. (Pubitemid 44706933)
71. Ejrnaes, M.; Filippi, C. M.; Martinic, M. M.; Ling, E. M.; Togher, L. M.; Crotty, S.; von Herrath, M. G., Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 2006, 203 (11), 2461-72. (Pubitemid 44664616)
72. Lin, D. Y.; Tanaka, Y.; Iwasaki, M.; Gittis, A. G.; Su, H. P.; Mikami, B.; Okazaki, T.; Honjo, T.; Minato, N.; Garboczi, D. N., The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors. Proc Natl Acad Sci U S A 2008, 105 (8), 3011-6. (Pubitemid 351723659)
73. Hagiwara, E.; Sacks, T.; Leitman-Klinman, S. F.; Klinman, D. M., Effect of HIV infection on the frequency of cytokine-secreting cells in human peripheral blood. AIDS Res Hum Retroviruses 1996, 12 (2), 127-133. (Pubitemid 26039711)
74. Li, M. O.; Sanjabi, S.; Flavell, R. A., Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006, 25 (3), 455-71 (Pubitemid 44354214)
75. Tinoco, R.; Alcalde, V.; Yang, Y.; Sauer, K.; Zuniga, E. I., Cellintrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo. Immunity 2009, 31 (1), 145-57.
76. Araki, K.; Turner, A. P.; Shaffer, V. O.; Gangappa, S.; Keller, S. A.; Bachmann, M. F.; Larsen, C. P.; Ahmed, R., mTOR regulates memory CD8 T-cell differentiation. Nature 2009, 460 (7251), 108-12.
77. Barouch, D. H., Challenges in the development of an HIV-1 vaccine. Nature 2008, 455 (7213), 613-9
78. Daniel, M. D.; Kirchhoff, F.; Czajak, S. C.; Sehgal, P. K.; Desrosiers, R. C., Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992, 258 (5090), 1938-41. (Pubitemid 23026733)
79. Deeks, S. G.; Walker, B. D., Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007, 27 (3), 406-16. (Pubitemid 47418678)
80. D'Souza, M.; Fontenot, A. P.; Mack, D. G.; Lozupone, C.; Dillon, S.; Meditz, A.; Wilson, C. C.; Connick, E.; Palmer, B. E., Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction. J Immunol 2007, 179 (3), 1979-87.
81. Suntharalingam, G.; Perry, M. R.; Ward, S.; Brett, S. J.; Castello-Cortes, A.; Brunner, M. D.; Panoskaltsis, N., Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006, 355 (10), 1018-28. (Pubitemid 44343545)
82. Trabattoni, D.; Saresella, M.; Biasin, M.; Boasso, A.; Piacentini, L.; Ferrante, P.; Dong, H.; Maserati, R.; Shearer, G. M.; Chen, L.; Clerici, M., B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood 2003, 101 (7), 2514-20. (Pubitemid 36857606)
83. Boasso, A.; Hardy, A. W.; Landay, A. L.; Martinson, J. L.; Anderson, S. A.; Dolan, M. J.; Clerici, M.; Shearer, G. M., PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes. Clin Immunol 2008, 129 (1), 132-44.
84. Marzec, M.; Zhang, Q.; Goradia, A.; Raghunath, P. N.; Liu, X.; Paessler, M.; Wang, H. Y.; Wysocka, M.; Cheng, M.; Ruggeri, B. A.; Wasik, M. A., Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1). Proc Natl Acad Sci U S A 2008, 105 (52), 20852-7.
85. Mestas, J.; Hughes, C. C., Of mice and not men: differences between mouse and human immunology. J Immunol 2004, 172 (5), 2731-8. (Pubitemid 38263654)
86. Silvestri, G.; Feinberg, M. B., Turnover of lymphocytes and conceptual paradigms in HIV infection. J Clin Invest 2003, 112 (6), 821-4. (Pubitemid 38063737)
87. Okazaki, T.; Honjo, T., The PD-1-PD-L pathway in immunological tolerance. Trends Immunol 2006, 27 (4), 195-201.
88. Berger, R.; Rotem-Yehudar, R.; Slama, G.; Landes, S.; Kneller, A.; Leiba, M.; Koren-Michowitz, M.; Shimoni, A.; Nagler, A., Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies. Clin Cancer Res 2008, 14 (10), 3044-51.
89. Brooks, D. G.; Ha, S. J.; Elsaesser, H.; Sharpe, A. H.; Freeman, G. J.; Oldstone, M. B., IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Proc Natl Acad Sci U S A 2008, 105 (51), 20428-33.
90. Ha, S. J.; Mueller, S. N.; Wherry, E. J.; Barber, D. L.; Aubert, R. D.; Sharpe, A. H.; Freeman, G. J.; Ahmed, R., Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. J Exp Med 2008, 205 (3), 543-55 (Pubitemid 351439302)
91. Brooks, D. G.; Lee, A. M.; Elsaesser, H.; McGavern, D. B.; Oldstone, M. B., IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J Exp Med 2008, 205 (3), 533-41. (Pubitemid 351439301)
92. Kumar, P.; Ban, H. S.; Kim, S. S.; Wu, H.; Pearson, T.; Greiner, D. L.; Laouar, A.; Yao, J.; Haridas, V.; Habiro, K.; Yang, Y. G.; Jeong, J. H.; Lee, K. Y.; Kim, Y. H.; Kim, S. W.; Peipp, M.; Fey, G. H.; Manjunath, N.; Shultz, L. D.; Lee, S. K.; Shankar, P., T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 2008, 134 (4), 577-86.
93. Shan, X.; Czar, M. J.; Bunnell, S. C.; Liu, P.; Liu, Y.; Schwartzberg, P. L.; Wange, R. L., Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation. Mol Cell Biol 2000, 20 (18), 6945-57.
94. Freeburn, R. W.; Wright, K. L.; Burgess, S. J.; Astoul, E.; Cantrell, D. A.; Ward, S. G., Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors. J Immunol 2002, 169 (10), 5441-50. (Pubitemid 35291641)
95. Lockyer, H. M.; Tran, E.; Nelson, B. H., STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. J Immunol 2007, 179 (8), 5301-8
96. Riley, J. L.; Mao, M.; Kobayashi, S.; Biery, M.; Burchard, J.; Cavet, G.; Gregson, B. P.; June, C. H.; Linsley, P. S., Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc Natl Acad Sci U S A 2002, 99 (18), 11790-5. (Pubitemid 34994477)
97. Kaufmann, D. E.; Walker, B. D., PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. J Immunol 2009, 182 (10), 5891-7.